Podcasts about life sciences

Today's guest is Dr. Krishna Bulusu. Holding a Ph.D. from the Institute of Cancer Research and completing his post-doctoral research at the University of Edinburgh, Krishna was, until recently,  an Honorary Lecturer for the Department of Neuroscience at the University of Sheffield. Krishna has worked at Astra Zeneca for the last six years and is currently the Director of Early Computational Oncology. In this episode, Krishna discusses how we can more effectively leverage endless streams of data in the life sciences industry to develop drugs and treatments with knowledge graphs. He also shares his perspective on the current impact of AI and where and how knowledge graphs are impacting workflows today. This episode is part of our AI is Here series sponsored by SambaNova Systems. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.

Dr. David Dranove is the Walter McNerney Distinguished Professor of Health Industry Management at Northwestern University's Kellogg Graduate School of Management, where he is also a Professor of Strategy and the faculty director of the Kellogg Ph.D. program. Dr. Lawton Burns is the James Joo-Jin Kim Professor at the Wharton School, University of Pennsylvania, where he is also a Professor of Healthcare Management, Professor of Management, and Codirector of the Roy and Diana Vagelos Program in Life Sciences and Management. Their latest book is titled Big Med: Megaproviders and the High Cost of Health Care in America.

The business of life sciences came into sharp focus after the pandemic highlighted the effectiveness of mRNA vaccines in protecting people against COVID. But what exactly is life sciences and is the recent market weakness a threat to future innovation — or an opportunity? In the latest episode of Exchanges at Goldman Sachs, Amit Sinha, Head of Life Sciences Investing in Goldman Sachs Asset Management, discusses the evolution of life sciences and how investors are approaching the risks and opportunities within the biotechnology sector.

美國中西部因為地理位置分散，這讓一些臺灣來的研究生覺得缺乏支持群體。今天，我們一起來跟毓鴻聊聊，她怎麼從意識到自己缺乏支持群體，到主動敦促自己加入不同的社團，並成為 2021 - 2022 年任期的 MTBA 共同會長。聽聽她怎麼組織自己的支持群體、以及從中尋找直得學習的對象，並把這份「互相支持」的溫暖持續的在 MTBA 發光發熱。 延伸閱讀 2022 MTBA 年會報名連結：https://www.eventbrite.com/e/2022-mtba-annual-symposium-tickets-386158760247 2022 MTBA 年會網站：https://mtbasymposium.wixsite.com/2022 第 003 號實驗：可以讓我拜你為師嗎? https://podcasts.apple.com/us/podcast/第-003-號實驗-可以讓我拜你為師嗎/id1555954868?i=1000520630337 雖然理想的老師會傳道、授業、解惑，甚至有教學相長這樣的師生互動關係，但我們從小到大聽到『導師』這兩個字的時候，通常都會想到班上的級任導師，所以在我們心中不免對導師有自然而然的尊重，也相對地會下意識地對導師這個名詞有上對下的階級感。那在美國遇到的『導師』，或者說是 mentor，又會是怎麼樣的呢？ 工作人員 內容製作：毓鴻、浩文、若晴、雯薇 後製：浩文、家明、天豪、雯薇、若晴、Mike 文案：浩文 音樂：雯薇 封面：毓鴻 上架：Mike 宣傳：Angel、雯薇

Fri, 12 Aug 2022 03:45:00 +0000 https://jungeanleger.podigee.io/312-borsepeople-im-podcast-s114 a5b5021cef6d21addcca57c9be49f464 Jürgen Wahl ist Vorstand der Strombörse EXAA und nebenbei Company Builder und Business Angel mit den Schwerpunkten, Umwelttechnik, Energiewirtschaft & -services („Clean Tech“), AgroFoodchain & -services („Life Sciences“), Gesundheitswesen („Health Tech“) sowie "Grünes Geld" (Fin Tech mit Impact). Im Werdegang-Talk spielen auch die Stationen Umweltministerium und McDonalds jeweils eine grosse Rolle. Für den US-Konzern hatte Jürgen etwas Wegweisendes aufgebaut, Ausläufer davon betreibt er mit der Gut GmbH noch heute. Freilich reden wir auch über die speziellen Herausforderungen am Strommarkt im Jahr 2022. Da Jürgen mit der EXAA im Palais Liechtenstei - in fast unmittelbarer Nachbarschaft unseres Büros - angesiedelt ist, ist das gemeinsame Hobby Musik in der gemeinsamen Variante nur aufgeschoben. https://www.exaa.at https://www.wahlpartners.com About: Die Serie Börsepeople findet m Rahmen von http://www.christian-drastil.com/podcast statt. Es handelt sich dabei um typische Personality- und Werdegang-Gespräche. Die Season 1 umfasst unter dem Motto „22 Börsepeople in Summer 22“ eben 22 Podcast-Talks, divers zusammengesetzt. Presenter ist die Management Factory (https://www.mf.ag ). Bewertungen bei Apple (oder auch Spot ify) machen mir Freude: https://podcasts.apple.com/at/podcast/christian-drastil-wiener-börse-sport-musik-und-mehr-my-life/id1484919130 . 312 full no Christian Drastil Comm.

Alex Guillen and Joe Lynch discuss tracking medical shipments. Alex is the Director of Sales, Life Science and Pharma Europe at Tive, the leading provider of real-time supply chain visibility insights that help logistics professionals actively manage their in-transit shipments' location and condition. About Alex Guillen Alex Guillen is an established executive with a proven record in global business and market development, with well-rounded experience in multicultural sales management and brand building. Alex has extensive experience and expertise in cold chain; as Director of Sales, Life Science and Pharma at Tive, Alex leads sales and business development within the company's rapid-growth Life Science division. Previously, Guillen served as a Board Member and leader of Corporate Strategy at SWITRACE S.A, a developer of temperature and humidity data loggers compliant to the Pharma and Biotech industries. Alex's extensive experience also includes serving as Global Cold Chain Director of Fisher Clinical Services, CEO of Escort Cold Chain Solutions SA, and Director for Commercial Operations for Novartis Vaccines. About Tive Tive is a leading provider of real-time supply chain visibility insights that help logistics professionals actively manage their in-transit shipments' location and condition. With Tive, shippers and logistics service providers (LSP) eliminate preventable delays, damage, and shipment failures. Tive‘s solution provides data generated by its industry-leading trackers allowing clients to actively optimize their shipments, improve their customers' experience, and unlock supply chain insights in an actionable real-time manner. Key Takeaways: Tracking Medical Shipments Alex Guillen is the Director of Sales, Life Science and Pharma Europe for Tive, which provides in-transit visibility solutions that help shipping and logistics professionals manage their shipments and eliminate preventable delays and damage. In the podcast interview, Joe and Alex discuss the critical importance of tracking medical shipments, including: Commercial pharmaceuticals Clinical pharmaceuticals Medical cold chain Cryogenic Organ transplants The bar is higher for medical and pharmaceutical shipments because a shipment that is late or out of temperature range could cause loss of life.The Tive Tracker is about the size of a deck of cards and it captures and transmits shipment data in real time with unprecedented accuracy. The Tracker provide real time alerts that enable shippers and their 3PL partners to respond and recover the shipment in the case of temperature breech, tampering, shock, damage, theft, and a variety of other factors. Tive enables shippers and their carrier partners to move from reactive to proactive, which is so important when transporting medical/pharma shipments. Tive provides flexible, scalable solutions bringing end-to-end visibility to supply chain professionals. In additional to medical and pharma, Tive provides solutions for the following supply chain problem areas: Location Tracking for High-Value Goods Chemicals Condition Monitoring Handling Damage Monitoring Damage Alerts for Electronics Shipments Port Delays Environmental Monitoring for Perishables Equipment Delivery Monitoring Automotive Supply Chain Optimization Learn More About Tracking Medical Shipments Alex's LinkedIn Tive LinkedIn Tive website The Tive Story with Krenar Komoni Every Shipment Matters with Jim Waters - YouTube Tive Solo 5G Pharma Tracker Tive Solo 5G Pharma Non-Lithium Tracker The Logistics of Logistics Podcast If you enjoy the podcast, please leave a positive review, subscribe, and share it with your friends and colleagues. The Logistics of Logistics Podcast: Google, Apple, Castbox, Spotify, Stitcher, PlayerFM, Tunein, Podbean, Owltail, Libsyn, Overcast Check out The Logistics of Logistics on Youtube

What you'll get out of this episodeCarrie talks with American Telemedicine Association (ATA) Vice President of Public Policy Kyle Zebley about how upcoming laws and policies will impact the future of virtual care.Listen to Discover: What the significance of the new bill, H.R. 4040, that was recently passed by the US House of Representatives, is and its chances of being signed into law What this new bill left out with respect to priorities within the telehealth stakeholder community How the proposed Medicare Physician Fee Schedule could shape virtual care in 2023 What kind of movement we're seeing in all 50 states around telehealth and virtual care policy About Our GuestKyle Zebley is Vice President of Public Policy at the American Telemedicine Association (ATA) and Executive Director of ATA Action. He is working with and on behalf of ATA and ATA Action members and like-minded organizations to eliminate barriers to the expansion of telehealth and ensure patients, providers, and payers can realize the benefits of virtual care.Previously, Kyle was the Chief of Staff in the Office of Global Affairs (OGA) at the U.S. Department of Health and Human Services (HHS). He collaborated with senior leadership from HHS, the White House and other cabinet departments to develop, advise, and promote U.S. global health policy, including in such policy areas as drug pricing, medical devices, global health security, and non-communicable diseases. Prior to HHS, he worked in Congress as a Legislative Director, leading a legislative team in developing policy and drafting legislation, particularly on matters concerning the House Committee on Ways and Means, the House Committee on the Budget and the House Committee on Education and the Workforce. Kyle started his career in Washington, D.C. as a Research Assistant at Public Opinion Strategies, where he worked on campaign strategies for clients running for U.S. President, U.S. Senate, the U.S. House of Representatives, state governor and state legislatures. Kyle is a sought-after policy expert and is frequently quoted in major media coverage on the topic of telehealth, including the Associated Press, Bloomberg, Kaiser Health News, Modern Healthcare, NPR, and Roll Call. In January 2022, Kyle was named by Politico as one of the “Four Washington players poised to shape digital health in 2022”.About the American Telemedicine AssociationAs the only organization completely focused on advancing telehealth, the ATA is committed to ensuring that everyone has access to safe, affordable, and appropriate care when and where they need it, enabling the system to do more good for more people.Additional Resources The American Telemedicine Association: “Telehealth. Is. Health. ATA is working to transform health and care through enhanced, efficient delivery.” ATA Action: “ATA Action, the ATA's affiliated trade organization, is our proactive response to the need for expanded advocacy in 2022 and the years to come. “ Connect with Kyle on LinkedIn Join the ConversationAre you a healthcare innovator? Tell us what topics and people you'd like us to cover in future episodes:Decoding Healthcare Innovation on LinkedInDecoding Healthcare on TwitterFollow our daily updates on LinkedIn:CarrieRebeccaAbout Your HostsCarrie Nixon and Rebecca Gwilt are partners at Nixon Gwilt Law, a healthcare innovation law firm exclusively serving Providers, Digital Health Companies, and Life Science Businesses seeking to transform the way we receive and experience healthcare. Find out more at NixonGwiltLaw.com.

Noubar Afeyan is the founder and CEO of life sciences innovation firm Flagship Pioneering. He's also the chairman and co-founder of Moderna, known for its Covid-19 vaccine. He has helped start more than 70 public and private healthcare and life sciences companies over the course of his career.Born in Beirut, Lebanon, to Armenian parents, he and his family fled the Lebanese Civil War to move to Montreal in 1975. Prior to founding Flagship Pioneering, Noubar was the founder and CEO of PerSeptive Biosystems, a leader in bio-instrumentation that grew to $100 million in annual revenues. He has written numerous scientific publications and is the inventor of over 100 patents.SUBSCRIBE TO OUR NEWSLETTER & STAY UPDATED > http://bit.ly/tfh-newsletterFOLLOW TFH ON INSTAGRAM > http://www.instagram.com/thefounderhourFOLLOW TFH ON TWITTER > http://www.twitter.com/thefounderhourINTERESTED IN BECOMING A SPONSOR? EMAIL US > partnerships@thefounderhour.com

Welcome to Episode 110 of The Spokesman Speaks podcast. In this episode, you'll meet Dr. Jason Ross – the new chair of Iowa State University's Department of Animal Science (part of ISU's College of Agriculture and Life Sciences). You'll also hear about the games and prizes that await you at Farm Bureau Park during this year's Iowa State Fair. Resource mentioned in this episode: Fairgoer attractions at Farm Bureau Park, during the 2022 Iowa State Fair

Jess Harrold is joined by news editor Pui-Guan Man and life sciences Evelina Grecenko for the latest weekly round-up of all the latest headlines. Grecenko tackles Oxford Biomedica's sale-and-leaseback plans, and the buzz around Manchester's Landmark Building. Man has news on industrial land values, Hammerson's latest results and a new digital twin of the commercial real estate market. But which is the better investment, industrial or life sciences? And how will they both fare in the quiz of the week, covering everything from the BBC to the celebrations of England's victory in the Euros?

In this episode, Cherise is joined by John Marx, AIA, Co-Founding Principal and Chief Artistic Officer at Form4 Architecture in San Francisco, California. John is responsible for developing Form4 Architecture's design vision and philosophical language. In this conversation, John shares his experience and insights into his work on the Innovation Curve Life Science Campus in Palo Alto, California. The project is a 265,895 square-foot, four-building, LEED Platinum life-science campus on the edge of the Stanford Research Park. The clear glass envelope with glass shading fins creates a crystalline form that evokes a sense of lightness and spirit. A mid-level blue horizontal ribbon shading element follows the shape of the classic R&D timeline; from creative spark, through trial and tribulation, to welcome success. To see project photos and details discussed, visit https://www.arcat.com/podcast (arcat.com/podcast) Allison Koo, Managing Director at Sand Hill Property Co., also shares her perspective as the client and building owner. Involved from land acquisition to occupancy and stabilization, Allision provides wide-ranging insight into an owner's decision making process. This project provided unique challenges and opportunities - A unique curved shading element and design feature required unconventional materials to build, the design balanced extensive use of glass with effective sun shading elements to help obtain LEED platinum certification, a creative and flexible design allowed the owner to effectively navigate volatility in the real estate market, and much more. If you enjoy this show, you can find similar content at https://gablmedia.com/ (Gābl Media).

Martina Bergant Marušič, Laboratory for Environmental and Life Sciences, University of Nova Gorica, SLOVENIA speaks on "Human papillomaviruses interfere with host cell processes during infection".

Listen to learn more...

CLICK HERE to listen to episode audio (3:58).Sections below are the following: Transcript of Audio Audio Notes and Acknowledgments ImagesExtra Information Sources Related Water Radio Episodes For Virginia Teachers (Relevant SOLs, etc.). Unless otherwise noted, all Web addresses mentioned were functional as of 8-1-22. TRANSCRIPT OF AUDIO From the Cumberland Gap to the Atlantic Ocean, this is Virginia Water Radio for the weeks of August 1 and August 8, 2022.  This is a revised repeat of an episode from August 2015. SOUNDS – ~4 sec – call from Great Egret then from Great Blue Heron. In this episode, we feature two mystery sounds, and a guest voice, to explore two striking birds—striking in looks, and striking in how they hunt.  Have a listen for about 30 seconds, and see if you can guess these two long-necked, long-legged wading birds. SOUNDS AND GUEST VOICE – ~30 sec – Voice: “At once he stirs and steps into the water, wading with imperial self-possession on his three-pronged, dragonish feet.  The water could not tremble less at the passage of his stilt legs as he stalks his dinner.  His neck arches like the bending of a lithe bow, one of a piece with the snapping arrow of his beak.” If you guessed, egret or heron, you're right!  The first call was from a Great Egret and the second from a Great Blue Heron.  The guest voice was Alyson Quinn, reading part of her “Lesson from an Egret,” inspired by a September 2007 visit to the Potomac River.  The word “egret” derives from an old German word for “heron,” a fitting origin for the many similarities between these two big birds.  The Great Egret and the Great Blue Heron are the two largest of 12 North American species of herons, egrets, and bitterns.  The Great Egret is strikingly white, while the Great Blue has only a partially white head over a bluish-gray body.  But a white subspecies of the Great Blue, called the Great White Heron, occurs in Florida.  Great Egrets and Great Blues both typically feed in shallow water, taking fish, amphibians, and other prey by waiting and watching quietly, then quickly striking with their long, sharp beaks.  The two species also share a history of having been widely hunted for their long plumes in the late 19th and early 20th centuries; the impact on their populations helped lead to nationwide bird-conservation efforts and organizations. Distinctive looks, behavior, and history make these two “Greats” a memorable and meaningful sight along Virginia's rivers, ponds, marshes, and other areas.  Thanks to Lang Elliott for permission to use this week's sounds, from the Stokes Field Guide to Bird Songs, and thanks to Alyson Quinn for permission to share her “Lesson from an Egret,” which gets this episode closing words. GUEST VOICE – ~18 sec – “I want to be more like the egret, with the patience to be still without exhaustion, to never mind the idle currents or be dazzled by the glamour of light on water; but, knowing the good thing I wait for, to coil my hope in constant readiness, and to act in brave certitude when it comes.” SHIP'S BELL Virginia Water Radio is produced by the Virginia Water Resources Research Center, part of Virginia Tech's College of Natural Resources and Environment.  For more Virginia water sounds, music, or information, visit us online at virginiawaterradio.org, or call the Water Center at (540) 231-5624.  Thanks to Ben Cosgrove for his version of “Shenandoah” to open and close this episode.  In Blacksburg, I'm Alan Raflo, thanking you for listening, and wishing you health, wisdom, and good water. AUDIO NOTES AND ACKNOWLEDGEMENTS This Virginia Water Radio episode revises and replaces Episode 277, 8-10-15. The sounds of the Great Egret and the Great Blue Heron were taken from the Stokes Field Guide to Bird Songs-Eastern Region CD set, by Lang Elliott with Donald and Lillian Stokes (Time Warner Audio Books, copyright 1997), used with permission of Lang Elliott, whose work is available online at the “Music of Nature” Web site, http://www.musicofnature.org/. Excerpts of “Lesson from an Egret” are courtesy of Alyson Quinn, from her blog “Winterpast” (September 21, 2007, post), available online at http://www.winterispast.blogspot.com/, used with permission.  Ms. Quinn made the recording after a visit to Algonkian Regional Park, located in Sterling, Va. (Loudoun County), part of the Northern Virginia Regional Park Authority.  More information about the park is available online at https://www.novaparks.com/parks/algonkian-regional-park. Click here if you'd like to hear the full version (2 min./22 sec.) of the “Shenandoah” arrangement/performance by Ben Cosgrove that opens and closes this episode.  More information about Mr. Cosgrove is available online at http://www.bencosgrove.com. IMAGES (Except as otherwise noted, photographs are by Virginia Water Radio.) Upper two images: Great Egret along the New River near Parrott, Va. (Pulaski County); photos by Robert Abraham, used with permission.  Third image: Great Blue Heron in a marsh at Wachapreague, Va. (Accomack County), October 5, 2007.  Bottom image: Great Blue Heron in a stormwater pond on the Virginia Tech campus in Blacksburg, July 28, 2015. EXTRA INFORMATION ABOUT GREAT EGRETS AND GREAT BLUE HERONS The following information is excerpted from the Virginia Department of Wildlife Resources (formerly Department of Game and Inland Fisheries), “Fish and Wildlife Information Service”: Great Egret “Life History” entry, online at https://services.dwr.virginia.gov/fwis/booklet.html?&bova=040032&Menu=_.Taxonomy&version=19202; and Great Blue Heron “Life History” entry, online at https://services.dwr.virginia.gov/fwis/booklet.html?&bova=040027&Menu=_.Taxonomy&version=19202. Great Egret Physical Description“Large, heavy, white heron with yellow-orange bill, black legs, long, slender neck, and long plumes extending beyond tail….” Behavior“Male selects territory that is used for hostile and sexual displays, copulation and nesting.  Adjacent feeding areas vigorously defended, both sexes defend.  …Migration occurs in fall and early spring along coast; winters further south than Virginia. …Foraging: alone in open situations; prefers fresh or brackish waters, openings in swamps, along streams or ponds; wader: stalks prey; known to participate in the 'leap-frog' feeding when initiated by cattle egret (Bubulcus ibis).  Prey are taken in shallow waters; prey usually includes insects, fish, frogs (adults and tadpoles), small birds, snakes, crayfish, and many others.  Nesting: in trees or thickets, 3-90 ft. above water in willows, holly, red cedar, cypress, and bayberry on dry ground in marshes.” Population Comments“Dangerously near extermination in early part of [20th] century due to plume hunting; population comeback hampered by loss of habitat, exposure to DDT and other toxic chemicals and metals. …[Predators include] crows and vultures….” Great Blue Heron Physical Description“Large grayish heron with yellowish bill, white on head, cinnamon on neck, and black legs,” Behavior“Territoriality: known to have feeding territory in non-breeding seasons, defended against members of same species.  Range: breeds from central Canada to northern Central America and winters from middle United States throughout Central America; in Virginia, is a permanent resident of the Coastal Plain. …Foraging: stands motionless in shallow water waiting on prey; occasionally fishes on the wing along watercourses, meadows and fields far from water.  They also take frogs, snakes, insects, and other aquatic animals.  Nesting: predominately in tall cedar and pine swamps, but may also be found on the ground, rock ledges, and sea cliffs; nests on platform of sticks, generally in colonies….” Aquatic/Terrestrial Associations“Salt or fresh shallow waters of lakes, ponds, marshes, streams, bays, oceans, tidal flats, and sandbars; feeds in surf, wet meadows, pastures, and dry fields.” SOURCES Used for Audio Cornell University Lab of Ornithology, “All About Birds,” online at http://www.allaboutbirds.org. Cornell University Lab of Ornithology, “Birds of the World,” online at https://birdsoftheworld.org/bow/home  (subscription required). Alice Jane Lippson and Robert L. Lippson, Life in the Chesapeake Bay, Johns Hopkins University Press, Baltimore, 2006. Merriam-Webster  Dictionary:“Egret,” online at https://www.merriam-webster.com/dictionary/egret;“Heron,” online at https://www.merriam-webster.com/dictionary/heron. National Audubon Society, “History of Audubon and Science-based Bird Conservation,” online at http://www.audubon.org/content/history-audubon-and-waterbird-conservation. Oxford Dictionaries/Oxford University Press:“Egret,” online at http://www.oxforddictionaries.com/us/definition/american_english/egret;“Heron,” online at http://www.oxforddictionaries.com/us/definition/american_english/heron. Chandler S. Robbins et al., A Guide to Field Identification of Birds of North America, St. Martin's Press, New York, 2001. Stan Tekiela, Birds of Virginia Field Guide, Adventure Publications, Inc., Cambridge, Minn., 2002. Virginia Department of Wildlife Resources (formerly Department of Game and Inland Fisheries), “Fish and Wildlife Information Service,” online at https://services.dwr.virginia.gov/fwis/:Great Blue Heron entry, online at https://services.dwr.virginia.gov/fwis/booklet.html?&bova=040027&Menu=_.Taxonomy&version=19202;Great Egret entry, online at https://services.dwr.virginia.gov/fwis/booklet.html?&bova=040032&Menu=_.Taxonomy&version=19202;“List of Native and Naturalized Fauna in Virginia, August 2020,” online (as a PDF) at https://dwr.virginia.gov/wp-content/uploads/virginia-native-naturalized-species.pdf.The Waterbird Society, online at https://waterbirds.org/. Joel C. Welty, The Life of Birds, W. B. Saunders Company, Philadelphia, Penn., 1975. For More Information about Birds in Virginia and Elsewhere Chesapeake Bay Program, “Birds,” online at https://www.chesapeakebay.net/discover/field-guide/all/birds/all. Cornell University Lab of Ornithology, “Merlin Photo ID.”  The application for mobile devices allows users to submit a bird photograph to get identification of the bird. Information is available online at http://merlin.allaboutbirds.org/. Cornell University Lab of Ornithology and the Audubon Society, “eBird,” online at https://ebird.org/home.  Here you can find locations of species observations made by contributors, and you can sign up to contribute your own observations. University of Michigan Museum of Zoology, “Animal Diversity Web,” online at https://animaldiversity.org. Virginia Society of Ornithology, online at http://www.virginiabirds.org/.  The Society is a non-profit organization dedicated to the study, conservation, and enjoyment of birds in the Commonwealth. Xeno-canto Foundation, online at http://www.xeno-canto.org/.  This site provides bird songs from around the world.  RELATED VIRGINIA WATER RADIO EPISODES All Water Radio episodes are listed by category at the Index link above (http://www.virginiawaterradio.org/p/index.html).  See particularly the “Birds” subject category. Following are links to some other episodes on birds in the family of herons, egrets, night-herons, and bitterns.Episode 118, 7-9-12 – Summertime sampler of birds, including Great Blue Heron. Episode 127, 9-10-12 – Green Heron. Episode 235, 10-13-14 – Black-crowned Night Heron.Episode 381, 8-14-17 – Midnight sounds near water, including Great Blue Heron.Episode 430, 7-23-18 – Marsh birds in Virginia, including Great Blue Heron and Least Bittern.Episode 478, 6-24-19 – Little Blue Heron.Episode 603, 11-15-21 – Fall bird migration, including Green Heron and Snowy Egret. FOR VIRGINIA TEACHERS – RELATED STANDARDS OF LEARNING (SOLs) AND OTHER INFORMATION Following are some Virginia Standards of Learning (SOLs) that may be supported by this episode's audio/transcript, sources, or other information included in this post.2020 Music SOLs SOLs at various grade levels that call for “examining the relationship of music to the other fine arts and other fields of knowledge.” 2018 Science SOLs Grades K-4: Living Systems and Processes1.5 – Animals, including humans, have basic life needs that allow them to survive. 2.5 – Living things are part of a system. 3.4 – Adaptations allow organisms to satisfy life needs and respond to the environment. 3.5 – Aquatic and terrestrial ecosystems support a diversity of organisms. 4.2 – Plants and animals have structures that distinguish them from one another and play vital roles in their ability to survive. 4.3 – Organisms, including humans, interact with one another and with the nonliving components in the ecosystem. Grades K-5: Earth ResourcesK.11 – Humans use resources.1.8 – Natural resources can be used responsibly.3.8 – Natural events and humans influence ecosystems.4.8 – Virginia has important natural resources.

Welcome to Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!   Today's episode features guest expert Ben Locwin! Ben is the VP of Project Solutions at Black Diamond Networks and has been working in the life sciences industry for over 25 years. Among other things, he has trained FDA inspectors and participated in the design of the Global Quality Metrics Initiative for the FDA.   The topic of today's discussion is the Real-World Evidence framework as defined by the FDA. We highly recommend listening to the previous episode on Real-World Data and Real-World Evidence before diving into this one.   Key Takeaways 00:17 Mandy introduces Ben back to the show 01:13 Today's topic is the Real-World Evidence framework 02:24 What is the FDA's definition of Real-World Evidence? 06:50 What is being looked at for the framework? 09:16 What are the 4 Vs of data? 11:18 How do you define your hypotheses in advance when looking at data? 15:44 Mandy reflects on today's discussion

A Clare native infectious diseases expert believes the government's decision to phase out Covid-19 testing this autumn is a mistake. Sixmilebridge native and former head of the School of Life Sciences at The University of Nottingham, Professor James McInerney, says widespread testing should be available given the number of repeat infections that are occurring.

Welcome to the Digital Health and Discovery podcast hosted by Dell Technologies. In this episode, host Chad Desilets is joined by Nick Brown, Chief Marketing Officer at Vyasa Analytics and Ken Berta, Global Business Lead for Life Sciences at Dell Technologies.Nick provides an overview of Vyasa's suite of solutions, describing how they leverage deep learning to help organizations solve their biggest data challenges. Ken highlights the particular challenges faced by hospitals and clinicians with imaging data storage, management and administration. Together they take a deep dive into Retina, Vyasa's image analytics application and discuss how this solution takes the administrative burden from clinicians allowing them to get to analysis and diagnostics faster. They offer some pertinent use cases and discuss what the Dell–Vyasa partnership looks like.

Wet labs at life science companies look and work the same pretty much everywhere. They're full of incubators, refrigerators, centrifuges, liquid handlers, gene sequencers, DNA and RNA synthesizers, and all sorts of other complex equipment. And a lot of these machines are automated—but the larger workflow in a life sciences R&D lab is very much not automated. For the most part it's individual researchers who decide how and when to use each piece of equipment, and individuals who move samples and materials back and forth between the machines. And that's a problem, because if you're trying to collect evidence for a scientific paper or a regulatory filing or trying to manufacture a product that's verifiably safe, you need to make sure that the same procedure gets carried out exactly the same way every time.Our guest this week, Artificial CEO David Fuller, believes that life sciences labs will always revolve around manual labor, but thinks there's a way to orchestrate the process more precisely. Artificial makes software that allows lab managers to create what he calls a digital twin of their entire laboratory. Inside this digital twin, data structures track what's happening with each piece of lab equipment and keep them in sync, even if they're from different manufacturers. The software provides what Fuller calls “a single pane of glass that makes it easier to see the state of the equipment and the science as it's running in your lab”…meaning what's happening, why it's happening, and what errors may be cropping up. Humans will always stay in the loop, but Fuller says the benefit for companies who orchestrate their labs in this way is that the data and the products coming out of the lab will be more consistent. Which will be even more important as laboratories start to act more like factories, where a lot of the actual production of biologic drugs or other materials happens.For a full transcript of this episode, please visit our show page at http://www.glorikian.com/podcastPlease rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac. 2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings & Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars. 6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner. 8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out. 9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.

Innovation in life sciences is crucial for many key industries in the United States and across the globe. It supports advances in human biotechnology, pharmaceuticals, health care policy, and beyond. Such advances would not always have been possible without the Bayh-Dole Act. Rob and Jackie sat down with Joe Allen, who served as a professional staffer on the U.S. Senate Judiciary Committee to former Senator Birch Bayh, to discuss the importance of the Bayh-Dole Act and the future of life sciences innovation. RelatedStephen Ezell, “The Bayh-Dole Act's Vital Importance to the U.S. Life-Sciences Innovation System” (ITIF, March 2019). “Preserving Bayh-Dole—the “Inspired” Law That Underpins U.S. Leadership in Life-Sciences Innovation” (ITIF Event, March 2019).Stephen Ezell, “How Japan Squandered Its Biopharmaceutical Competitiveness: A Cautionary Tale” (ITIF, July 2022).

On this special episode of the Futurum Tech Webcast – Interview Series I am joined Aparna Seksaria, Global Practice Lead R&D Solutions, Life Sciences. This is the second episode in a series — done in partnership with SAP — where I will be speaking with advisors and executives across several different industries on the state of their industry and what we can expect in the future. In our conversation we discussed the following: The areas of opportunities for the life sciences industry A deep dive into how the life sciences organizations can use industry cloud solutions augmented with additional technologies to foster growth A look into how life sciences organizations have tackled the value chain challenges brought about by the pandemic An exploration into ways organizations can produce products faster and more sustainably while reducing costs The life sciences industry, like many other industries, had to rapidly accelerate transformation processes throughout the pandemic and many organizations are still dealing with these changes. My conversation Aparna explores how these changes are playing out and the role technology is playing. It's definitely one you don't want to miss. If you'd like to learn more about the industry, be sure to check out our research brief The Evolution of Life Sciences Organizations: How Embracing Innovation Technology Solutions is Critical to Success.

Architect Jim Collins talks about the URI campus quad which are comprised of different buildings. CBLS represents the first phase of the North District at URI, a new science and technology hub which transforms a series of irregular campus spaces into two, well-defined campus quadrangles bordered by a new pedestrian promenade. The highly cost-effective, LEED Gold building accommodates 30 faculty members and their research groups, in addition to teaching labs, classrooms, a 300-seat auditorium, a genomics lab and a GSL-3 lab for life sciences education.  The relationship that these buildings have to the quad and to each other holds them together as an academic ensemble of buildings.

This week's podcast has two parts. In the first section University of Idaho lactation specialist Dr. Shelley McGuire discusses the recent paper that claims to have found the herbicide glyphosate in breast milk. In the second half Gabe Ignetti from the Ecomodernist Society of North America discusses an environmental movement that embraces science, including biotechnology and nuclear power. 

Seems like there is always new research coming out about the benefits of coffee. This episode begins with another one – and maybe one you haven't heard before. You just need to drink 3 cups a day – or more. https://rightasrain.uwmedicine.org/body/food/can-your-coffee-habit-help-protect-you-skin-cancer Probably everyone has been witness to a bully or some other inappropriate behavior and didn't intervene. And later regretted it. It's called “The Bystander Effect.” Why don't people step in and callout bullies? Why do we leave it to someone else or no one at all? What would happen if we did step in when we see bad behavior in others? What's the best way to intervene and not escalate a situation? Here to discuss and answer these questions is psychologist Catherine Sanderson, a professor in Life Sciences at Amherst College and the author of Why We Act. Turning: Bystanders into Moral Rebels (https://amzn.to/3vfUgrs) Summer is the favorite time of year for many people. Yet, too much of a good thing can have consequences. Listen as I discuss how summer weather can impact your mood and state of mind. https://www.livescience.com/21431-hot-temperatures-mood.html Idioms are interesting. They are those little phrases that work their way into our language to help us make a point. For example, play with fire, drink the Kool-Aid, move the goal posts or drop the mic. Where do these phrases come from? Why do some idioms last and others don't? Do other languages also have idioms or is English unique in that way. Joining me to talk about this is Gareth Carrol a senior lecturer and researcher in linguistics at the University of Birmingham and author of the book, Jumping Sharks and Dropping Mics: Modern Idioms and Where The Come From (https://amzn.to/3J5XnaX). PLEASE SUPPORT OUR SPONSORS! We really like The Jordan Harbinger Show! Check out https://jordanharbinger.com/start OR search for it on Apple Podcasts, Spotify or wherever you listen!  Get $100 off of your first month with Talkspace! To match with a licensed therapist today, go to https://Talkspace.com & make sure to use the code SYSK to get $100 off of your first month! Go to https://Shopify.com/sysk for a FREE fourteen-day trial and get full access to Shopify's entire suite of features! Redeem your rewards for cash in any amount, at any time, with Discover Card! Learn more at https://Discover.com/RedeemRewards https://www.geico.com Bundle your policies and save! It's Geico easy! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Tara Sander Lee is the Senior Fellow and Director of Life Sciences at the Charlotte Lozier Institute, an organization dedicated to policies and practices to protect the sanctity of human life. She is a scientist with 20 years of experience in academic and clinical medicine with an emphasis on the cause of pediatric disease. She obtained a Ph.D. in Biochemistry from the Medical College of WI and fellowship training at Harvard Medical School and Boston Children's Hospital. Dr. Sander Lee is published in various medical journals and textbooks, including her recent co-authored manuscript in the journal Issues in Law and Medicine, -The Perinatal Revolution.- She is a contributor to the book, Choose Life- Answering Key Claims of Abortion Defenders with Compassion. Her chapter is -Knit Together in a Mother's Womb- The Biology of Prenatal Development.- She also served as molecular pathology inspector for the College of American Pathologists and scientific consultant for various entities including the Milwaukee County Medical Examiner, Children's Hospital of Wisconsin, and TAI Diagnostics.--The Biden Administration has become unglued since the United States Supreme Court affirmed that there is no right to abortion granted in our Constitution. As a result, the President is trying to use executive orders or rule making from his cabinet departments in an effort to force hospitals and doctors to violate the Hippocratic Oath and perform this gruesome procedure which takes the life of an innocent baby. Protests have taken place in cities across the country. Even in small town America, 2 or 3 will gather on a downtown street corner bearing signs which read -my body, my choice.-

Yaniv Sneor, co-founder of the Mid Atlantic Bio Angels (MABA), a life science angel investor group, joins Karen Rands on The Compassionate Capitalist Show to discuss the purpose and process of the investor network. The life cycle and milestones used to measure progress and assess risk of Life Sciences companies as an early stage, pre-revenue company, are different than tech or consumer product companies. Often there isn't a tangible MVP (Minimum Viable Product), a prototype, or a beta to validate that the innovation works. Yet MABA seems to have broken the code and figured out how to evaluate, invest, and create a return on investment in the biomed, med tech, life sciences segment. Investors committed to bringing bio and medical innovations to the market are the minority in the broad scope of angel investors and angel investor groups. Learning from those investors that have figured out how to invest wisely and profiably in this complex sector is incredibly valuable. Yaniv and Karen talk about: - Key Milestones to consider that reduce inherent risk - Importance of getting to exit without VC money - How MABA offers Direct Investment and SideCar "Index" Fund Yaniv has held every C-level position and led his companies through merger, acquisition, capitalization, and turnaround leadership with companies ranging from start-up to growth stage. Mr. Sneor is also currently the CEO of Native State Therapeutics, an early state biotechnology company in the neurodegeneration field. More information: MABA Members http://bioangels.net and their co-investment Sidecar Fund https://sidecarfund.bioangels.net/, for non MABA member investors Educated as an economist, Karen Rands is leading the Compassionate Capitalist Movement and author of the best selling Inside Secrets to Angel Investing. http:/InsideSecretstoAngelInvesting.com Video version: https://youtu.be/hsKWwjuLsQY

From virtual-appointments, to artificial intelligence, to data management and fighting cyber-attacks, Dell's Arshad Farhad helps healthcare providers to see how technology can support their work.Arshad is Dell Technology's Chief Technology Officer in Healthcare and Life Sciences for Europe, Middle East and Africa. He's also working towards his doctorate in Federated Learning for AI (using ML and Data Science) to improve patient care using wearable and Internet of Medical Things sensors.In this episode, Arshad tells Gareth why technology is the future of healthcare and how medicine can be more effective if it is data-driven.Why Arshad is passionate about healthcare and technology (2.05)Arshad's PHD journey and challenges (3.17)Healthcare in the next 5 to 10 years (4.35)Ethical dilemmas (8.35)Robotic surgery (9.53)Wearable technology in healthcare (11.30)How does the UK healthcare technology compare to other countries (15.41)The last 12 months in healthcare technology (19.17)Smart hospitals (21.00)What problems is the healthcare sector facing (22.28)How Dell is helping to address these challenges (25.09)Edge-based healthcare (25.40)AI healthcare (26.50)Data management (27.15)Data security (29.52)Cloud technology (31.30)Arshad's role as Chief Technology Officer (33.27)What Arshad believes makes a good leader (36.27)Leadership in the pandemic (37.34)Who inspires Arshad (38.27)

Innovation without the right outcomes is a recipe for failure for both the project and the business. This simple notion seems obvious, yet countless companies get it wrong from the start, never realizing the missed opportunities for winning products with sustainable value! As a result, mediocre products go out the door to customers every day. In the worst cases, medical device companies have invested 6 to 10 years in a product's development, only to find out that it was the wrong product!   So, how do we remedy this issue? Our recent guest, Tony Ulwick might just have the answer! Tony is the pioneer of Jobs-to-be-Done Theory, the inventor of the Outcome-Driven Innovation® (ODI) process, and the founder of strategy and innovation consulting firm Strategyn. Tony has applied his ODI process at some of the world's leading companies and across nearly all industries to inform breakthrough innovations—achieving a success rate that is 5 times better than the industry average. Philip Kotler calls Tony “the Deming of innovation” and credits him with bringing predictability to innovation. Published in Harvard Business Review and MIT Sloan Management Review, Tony is also the author of best sellers What Customers Want and JOBS TO BE DONE: Theory to Practice

Dr. Tara Sander Lee is the Senior Fellow and Director of Life Sciences at the Charlotte Lozier Institute, an organization dedicated to policies and practices to protect the sanctity of human life. She is a scientist with 20 years of experience in academic and clinical medicine with an emphasis on the cause of pediatric disease. She obtained a Ph.D. in Biochemistry from the Medical College of WI and fellowship training at Harvard Medical School and Boston Children's Hospital. Dr. Sander Lee is published in various medical journals and textbooks, including her recent co-authored manuscript in the journal Issues in Law and Medicine, -The Perinatal Revolution.- She is a contributor to the book, Choose Life- Answering Key Claims of Abortion Defenders with Compassion. Her chapter is -Knit Together in a Mother's Womb- The Biology of Prenatal Development.- She also served as molecular pathology inspector for the College of American Pathologists and scientific consultant for various entities including the Milwaukee County Medical Examiner, Children's Hospital of Wisconsin, and TAI Diagnostics.--The Biden Administration has become unglued since the United States Supreme Court affirmed that there is no right to abortion granted in our Constitution. As a result, the President is trying to use executive orders or rule making from his cabinet departments in an effort to force hospitals and doctors to violate the Hippocratic Oath and perform this gruesome procedure which takes the life of an innocent baby. Protests have taken place in cities across the country. Even in small town America, 2 or 3 will gather on a downtown street corner bearing signs which read -my body, my choice.-

What you'll get out of this episodeGuest hosts Reema Taneja, Esq., and Kaitlyn O'Connor, Esq. of Nixon Gwilt Law sit in for a vacationing Carrie and Rebecca in this episode. These veterinary telehealth legal experts (and dog lovers!) talk to Mark Cushing, Founder and CEO of the Animal Policy Group, about the growing market for “TelePet,” which is telehealth for pets.Listen to this episode to discover: How TelePet has evolved over time What challenges currently exist What need TelePet fills in veterinary care  What stakeholders can do to help expand access to TelePet services About our GuestMark Cushing is the Founder & CEO of the Animal Policy Group. A long-time political strategist, government regulatory advisor, corporate executive and former litigator, Mark focuses his advocacy practice on providing high-level strategic advice and services to clients with needs at any level of government, and key trade/industry associations in the U.S., Canada and Mexico.Since 2004, Mark has specialized in animal health, animal welfare, veterinary and veterinary educational issues and accreditation, developing a cutting-edge practice across these sectors. He currently leads several industry coalitions and initiatives. Mark has guided successful accreditations for a growing list of veterinary colleges, and is co-founder of the Veterinary Virtual Care Association.Mark has recently penned Pet Nation, a book that tells the inside story of how companion animals are transforming our homes, culture, and economy. Mark is a frequent speaker at veterinary medicine and other animal policy-related conferences.About the CompanyThe Animal Policy Group monitors all 50 state Legislatures, Veterinary Medical Boards and Pharmacy Boards 365 days a year. Then they rely on relationships in each state, and industry partners, to implement effective plans for success.Additional Resources Learn more about the Animal Policy Group Check out Mark's book, Pet Nation: The Inside Story of How Companion Animals Are Transforming Our Homes, Culture, and Economy Watch Reema and Kaitlyn's recent webinar on the Top 3 Legal Considerations for TelePet Startups Join the ConversationAre you a healthcare innovator? Tell us what topics and people you'd like us to cover in future episodes:Decoding Healthcare Innovation on LinkedInDecoding Healthcare on TwitterFollow our daily updates on LinkedIn:CarrieRebeccaAbout Your HostsCarrie Nixon and Rebecca Gwilt are partners at Nixon Gwilt Law, a healthcare innovation law firm exclusively serving Providers, Digital Health Companies, and Life Science Businesses seeking to transform the way we receive and experience healthcare. Find out more at NixonGwiltLaw.com. 

Hosted by Andrew Keen, Keen On features conversations with some of the world's leading thinkers and writers about the economic, political, and technological issues being discussed in the news, right now. In this episode, Andrew is joined by Harald H.H.W. Schmidt, author of of The End of Medicine as We Know It— And Why Your Health Has a Future. Professor Harald H.H.W. Schmidt is a German physician and pharmacist, chairing the Department of Pharmacology and Personalized Medicine, Faculty of Health, Medicine and Life Sciences, at the University of Maastricht. Netherlands.After his double degree in medicine and pharmacy, he distinguished himself as an internationally highly recognized researcher in the fields of drug therapy, elucidation of the causes of disease and prevention.He headed and heads various research programs as an Advanced Investigator of the European Research Council (ERC), coordinator of Horizon 2020 project REPO-TRIAL and Collaboration on Science and Technology (COST) actions.He founded companies with which he brought therapeutics and diagnostics to market, is co-editor of the journal Network and Systems Medicine, and has written over 200 peer-reviewed international publications, reviews and books with a Hirsch factor of 92 and over 30,000 citations.Part of his early research training he conducted in the USA with the later Nobel Laureate, Ferid Murad, and led international institutes and research centers in Germany, Australia and the Netherlands. He is also the editor of a textbook on drug therapy and several expert handbooks in drug therapy.As a broadly experience and critical analyst, he recognized the fundamental conceptual crisis in medicine and became one of the pioneers of systems medicine, i.e. a complete redefinition of what we actually call a disease, how we organize medicine and how we use Big Data to heal rather than treat and ideally to prevent diseases.He is a dedicated, international keynote speaker, podcaster, YouTuber and initiator of the German patientenwiewir.de patient platform. One of his hobbies is sports. For a long time, he was a soccer referee. His social engagement at Rotary International and different clubs introduced him to Homeless World Cup and sharpened is awareness and engagement for homeless people. Recently, his interested in sociocritical and political contemporary art recently started him to create his own small oeuvre under the concept of realitychanges.de, which has been selected for several solo and group exhibitions Learn more about your ad choices. Visit megaphone.fm/adchoices

我們常聽人說實驗室生活的困難，像是實驗做不出來的壓力，和與老闆以及實驗室同仁溝通的挫折。這些負面的困難有消耗我們對科學研究的熱情。也會讓我們逐漸忘記那份讓我們想走上研究之路的衝動和喜悅。於是慢慢地，我們會自嘲的說：「哎呀，就是當時年紀輕不懂事啊！」不過真的是如此嗎？讓我們一起聽聽維樂的故事。聽他說怎麼樣從一個簡單的觀察，一路走過長時間的追尋，並在過程中找到讓自己開心的興趣，最後達到某種平衡。 延伸閱讀 2022 MTBA 年會報名連結：https://www.eventbrite.com/e/2022-mtba-annual-symposium-tickets-386158760247 2022 MTBA 年會網站：https://mtbasymposium.wixsite.com/2022 維樂實驗室成員招募中，聯絡方式：wangweilelab@gmail.com 興趣探索系列 第 008 號實驗：花椰菜與他的家族成員 - 天豪 https://podcasts.apple.com/us/podcast/第-008-號實驗-花椰菜與他的家族成員-天豪/id1555954868?i=1000529297550 你是否曾經在美國逛過農夫市集，好奇農夫市集跟一般的超市有什麼差異？或曾跟小編一樣阮囊羞澀時端詳著超市的有機蔬菜想著是否真的值那個價？美國各個地區對基改作物的態度不盡相同，這是惡魔黨的陰謀，還是媒體過度誇大？這集我們邀請現在在紐約大學從事植物基因體研究的天豪，來跟三腳貓們分享他在美國闖蕩的這幾年間，穿梭在農夫市集經歷的一些趣聞，以及他怎麼看基改和飲食的關係。 第 010 號實驗：當我們不在實驗室 https://podcasts.apple.com/us/podcast/第-010-號實驗-當我們不在實驗室/id1555954868?i=1000532090903 很多人在美國求學或工作的階段，都會逐步發展自己的興趣。興趣讓我們從繁忙的日常中尋找一個寄託，協助我們調整生活的節奏。這集三腳貓們各自談及當他們不在實驗室裡，是怎樣的活動讓他們可以放下心中壓力，以及從興趣為出發點如何看待自身的變化，找回自己身為「人」的身份。 實驗室困境系列： 第 011 號實驗：這組數據爛爆了 - 若晴 https://podcasts.apple.com/us/podcast/第-011-號實驗-這組數據爛爆了-若晴/id1555954868?i=1000533365590 延續之前對於美國實驗室與研究生活的討論。或許你覺得你只是一個很平凡的研究生，又或者你曾是學弟妹口中的學霸。在念博班的過程中，都可能會因為挑戰而開始自我懷疑。今天三腳貓與朋友想跟你一起聊聊我們自己經歷的故事，和走過黑暗幽谷後發現的一些可行方法。 工作人員 內容製作：維樂、浩文、若晴、天豪 後製：毓鴻、家明、天豪、雯薇、若晴、Mike 文案：浩文 音樂：雯薇 封面：毓鴻 上架：Mike 宣傳：Angel、雯薇

Today on the Take on Board podcast, I'm speaking with Shweta Maniar about how she networked her way to the board room, including non-traditional roles and background and how that can bring diversity of experience, thought and decisions to the boardroom.Shweta is on the boards of Seaspine (NASDAQ: SPNE), a global spinal technology company, and for RXSight (NASDAQ: RXST), an ophthalmic medical technology company. Shweta brings an extensive network of established healthcare system relationships across Digital Health & Technology, Investor, Pharmaceutical, Medical Device, and Hospital Systems Industries. She is passionate about keeping current with trends in medical devices, data, wearables, IoT, EHR (EMR), and machine learning.At Google Cloud, Shweta is the strategy and market solution leader responsible for BioPharma in Healthcare and Life Sciences. Shweta has quickly risen through the ranks as a well-known innovator, game-changer, and relationship ambassador. She has proven time and time again how valuable relationships can be by enabling dozens of start-up firms with access to capital from Federal grants and VC firms alike.Shweta Maniar on LinkedIn and TwitterFrom this Episode:SXSW Keynote: Technological Determinants of Health in the FutureYou might want to:Join the Take on Board Facebook communityJoin the Take on Board LinkedIn communityFollow along on TwitterWork with meJoin the Take on Board: Kickstarter group programJoin the Take on Board: Accelerator group programFind out more about meContact me See acast.com/privacy for privacy and opt-out information.

In der Nachmittagsfolge begrüßen wir heute Tim Blazytko, Chief Scientist und Co-Founder von Emproof, und sprechen mit ihm über die erfolgreiche Seed-Finanzierung in Höhe von 2 Millionen Euro. Emproof bietet innovative Sicherheitslösungen für Embedded Systems, die mehrere Ebenen des Software-Sicherheits-Stacks adressieren. Die automatisierten Lösungen des Unternehmens verhindern Cyber-Angriffe, wie beispielsweise das Ausnutzen von Software-Schwachstellen, sowie Produktpiraterie und -manipulation. Die Lösungen des Embedded-Security-Startups senken die kostspieligen Risiken im Zusammenhang mit Cyber-Angriffen und können die Unternehmen so vor Reputationsschäden und Produkthaftungsansprüchen schützen. Eine Lösung stellt dabei die von Emproof entwickelte NYX Software Suite dar. Diese soll Reverse-Engineering und Firmware-Manipulationen verhindern und lässt sich in jede Firmware-Entwicklungspipeline integrieren. Emproof wurde im Jahr 2017 von Marc Fyrbiak, Philipp Koppe, Benjamin Kollenda und Julian Stratmann am Horst Görtz Institut für IT-Sicherheit gegründet. Nun hat das Bochumer Startup in einer Seed-Finanzierungsrunde 2 Millionen Euro eingesammelt. Zu den Investoren zählen die niederländische Investmentgesellschaft TIIN Capital mit ihrem Dutch Security TechFund, der deutsche High-Tech Gründerfonds und der französische Venture-Capital-Fonds Cyber Impact. Der Dutch Security TechFund ist ein Cybersicherheitsfonds für Startups und Scaleups. Er wird u.a. von einer Gruppe informeller Investoren und Family Offices, der Stadt Den Haag, der regionalen Investmentgesellschaft InnovationQuarter, KPN Ventures, dem Investeringsfonds Groningen und dem Ministerium für Wirtschaft und Klimapolitik finanziert. Der High-Tech Gründerfonds ist ein Seed-Investor mit Fokus auf High-Tech Gründungen aus den Bereichen Digital Tech, Industrial-Tech, Life Sciences und Chemie. Mit einem Volumen von rund 900 Millionen Euro hat der HTGF seit 2005 mehr als 650 Startups begleitet. Zu den Portfoliounternehmen des HTGFs gehören u.a. Ebenbuild, Industrial Technology and Witchcraft, Aegiq, Altavo, Operaize, Anybill, FinMarie, Nebula Biocides, Smarterials Technology, SideCaps, Coinpanion, LEON Mobility, Sky Engine AI, FarmInsect, Urban Ground, Inovedis, FundaMental Pharma, WMT, Traceless materials, Cutanos, QphoX, Dimpora, Etvas, Venly und Sewts. Cyber Impact ist ein unternehmerischer Fonds, der seine Erfahrung, sein Fachwissen und sein Netzwerk einsetzt, um das kommerzielle Wachstum der Unternehmen in seinem Portfolio zu beschleunigen. Zum Unternehmensportfolio gehören u.a. Cryptr und Augmented Ciso. Mit dem frischen Kapital möchte Emproof seine Produktpalette weiter ausbauen und Kunden in Europa und den USA bedienen. One more thing wird präsentiert von OMR Reviews – Finde die richtige Software für Dein Business. Wenn auch Du Dein Lieblingstool bewerten willst, schreibe eine Review auf OMR Reviews unter https://moin.omr.com/insider. Dafür erhältst du einen 15€ Amazon Gutschein.

Tonight on We Are Paradox Media's "Late Night in The Rockies" Weekend Host TessaTNT is joined by Independant Researcher Jim Moses. This evening we will be discussing the "Resurrection of The True Life Sciences".